Kærtor

Kaertor Foundation is a non-profit organization based in Spain dedicated to accelerating drug discovery through open innovation and public-private partnerships. The foundation operates the I2D2 (Incubation and Innovation in Drug Discovery) program, which bridges the gap between basic academic research and industrial drug development. By providing expertise in medicinal chemistry, high-throughput screening, and pharmacology, Kaertor helps transform early-stage biological discoveries into viable drug candidates. They have established significant collaborations with major pharmaceutical companies like Janssen and Eli Lilly to advance programs in oncology, neurology, and rare diseases. The foundation plays a pivotal role in the Galician biotechnology ecosystem by de-risking innovative projects for further investment.